Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 20, 2011 - Issue 10
Submit an article Journal homepage
1,304
Views
155
CrossRef citations to date
0
Altmetric
Reviews

Targeting Mcl-1 for the therapy of cancer

Bridget A Quinn Virginia Commonwealth University, School of Medicine, Department of Human and Molecular Genetics, Richmond, VA, [email protected]
,
Rupesh Dash Virginia Commonwealth University, School of Medicine, Department of Human and Molecular Genetics, Richmond, VA, [email protected]
,
Belal Azab Virginia Commonwealth University, School of Medicine, Department of Human and Molecular Genetics, Richmond, VA, [email protected]
,
Siddik Sarkar Virginia Commonwealth University, School of Medicine, Department of Human and Molecular Genetics, Richmond, VA, [email protected]
,
Swadesh K Das Virginia Commonwealth University, School of Medicine, Department of Human and Molecular Genetics, Richmond, VA, [email protected]
,
Sachin Kumar Virginia Commonwealth University, School of Medicine, Department of Human and Molecular Genetics, Richmond, VA, [email protected]
,
Regina A Oyesanya Virginia Commonwealth University, School of Medicine, Department of Human and Molecular Genetics, Richmond, VA, [email protected]
,
Santanu Dasgupta Virginia Commonwealth University, School of Medicine, Department of Human and Molecular Genetics, Richmond, VA, [email protected]; Virginia Commonwealth University, VCU Institute of Molecular Medicine, School of Medicine, Richmond, VA, USA; Virginia Commonwealth University, VCU Massey Cancer Center, School of Medicine, Richmond, VA, USA
,
Paul Dent Virginia Commonwealth University, School of Medicine, Department of Neurosurgery, Richmond, VA, USA; Virginia Commonwealth University, VCU Institute of Molecular Medicine, School of Medicine, Richmond, VA, USA; Virginia Commonwealth University, VCU Massey Cancer Center, School of Medicine, Richmond, VA, USA
,
Steven Grant Virginia Commonwealth University, School of Medicine, Department of Medicine, Richmond, VA, USA; Virginia Commonwealth University, VCU Institute of Molecular Medicine, School of Medicine, Richmond, VA, USA; Virginia Commonwealth University, VCU Massey Cancer Center, School of Medicine, Richmond, VA, USA
,
Mohamed Rahmani Virginia Commonwealth University, School of Medicine, Department of Medicine, Richmond, VA, USA
,
David T Curiel Washington University School of Medicine, Department of Radiation Oncology, St. Louis, MO, USA
,
Igor Dmitriev Washington University School of Medicine, Department of Radiation Oncology, St. Louis, MO, USA
,
Michael Hedvat Virginia Commonwealth University, School of Medicine, Department of Human and Molecular Genetics, Richmond, VA, [email protected];Sanford-Burnham Medical Research Institute, La Jolla, CA, USA
,
Jun WeiSanford-Burnham Medical Research Institute, La Jolla, CA, USA
,
Bainan WuSanford-Burnham Medical Research Institute, La Jolla, CA, USA
,
John L StebbinsSanford-Burnham Medical Research Institute, La Jolla, CA, USA
,
John C ReedSanford-Burnham Medical Research Institute, La Jolla, CA, USA
,
Maurizio PellecchiaSanford-Burnham Medical Research Institute, La Jolla, CA, USA
,
Devanand Sarkar Virginia Commonwealth University, School of Medicine, Department of Human and Molecular Genetics, Richmond, VA, [email protected]; Virginia Commonwealth University, VCU Institute of Molecular Medicine, School of Medicine, Richmond, VA, USA; Virginia Commonwealth University, VCU Massey Cancer Center, School of Medicine, Richmond, VA, USA
&
Paul B Fisher Virginia Commonwealth University, School of Medicine, Department of Human and Molecular Genetics, Richmond, VA, [email protected]; Virginia Commonwealth University, VCU Institute of Molecular Medicine, School of Medicine, Richmond, VA, USA; Virginia Commonwealth University, VCU Massey Cancer Center, School of Medicine, Richmond, VA, USA
 show all
Pages 1397-1411 | Published online: 19 Aug 2011

Citations (155)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (10)

Xiaoli Xu, Minjian Xiong, Haiyan Ye, Yonglei Qi & Ying Zhao. (2023) Analysis of single-cell sequencing results of an elderly patient with myeloid leukemia reveals high expression of multiple oncogenes in monocytes and hematopoietic stem cells. Hematology 28:1.
Read now
Wenjun Liu, Mohammad Khalid, Shadma Wahab, Mohd Faizan Siddiqui, Shaheer Hasan Khan, Mohd Sadiq & Zeenat Khatoon. (2023) A multitier virtual screening study of phytoconstituents as Myeloid Cell Leukemias 1 inhibitors. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-10.
Read now
Xiangxuan Zhao, Feng Wen, Wei Wang, Zaiming Lu & Qiyong Guo. (2019) Actinidia arguta (Hardy Kiwi) Root Extract Exerts Anti-cancer Effects via Mcl-1-Mediated Apoptosis in Cholangiocarcinoma. Nutrition and Cancer 71:2, pages 246-256.
Read now
Adelaide IJ Young, Paul Timpson, David Gallego-Ortega, Christopher J. Ormandy & Samantha R. Oakes. (2018) Myeloid cell leukemia 1 (MCL-1), an unexpected modulator of protein kinase signaling during invasion. Cell Adhesion & Migration 12:6, pages 513-523.
Read now
Jane Huang, Wayne Fairbrother & John C Reed. (2015) Therapeutic targeting of Bcl-2 family for treatment of B-cell malignancies. Expert Review of Hematology 8:3, pages 283-297.
Read now
Yan Liu, Jiao Ge, Qiang Li, Xia Guo, Ling Gu, Zhi-Gui Ma, Xi-Hong Li & Yi-Ping Zhu. (2014) Low-dose anisomycin sensitizes glucocorticoid-resistant T-acute lymphoblastic leukemia CEM-C1 cells to dexamethasone-induced apoptosis through activation of glucocorticoid receptor and p38-MAPK/JNK. Leukemia & Lymphoma 55:9, pages 2179-2188.
Read now
Shilpa Bhatia, Luni Emdad, Swadesh K Das, Hossein Hamed, Paul Dent, Devanand Sarkar & Paul B Fisher. (2014) Non-BRAF targeted therapies for melanoma: protein kinase inhibitors in Phase II clinical trials. Expert Opinion on Investigational Drugs 23:4, pages 489-500.
Read now
Shibu Thomas, Bridget A Quinn, Swadesh K Das, Rupesh Dash, Luni Emdad, Santanu Dasgupta, Xiang-Yang Wang, Paul Dent, John C Reed, Maurizio Pellecchia, Devanand Sarkar & Paul B Fisher. (2013) Targeting the Bcl-2 family for cancer therapy. Expert Opinion on Therapeutic Targets 17:1, pages 61-75.
Read now
Laurence Booth, Nichola Cruickshanks, Thomas Ridder, Ching-Shih Chen, Steven Grant & Paul Dent. (2012) OSU-03012 interacts with lapatinib to kill brain cancer cells. Cancer Biology & Therapy 13:14, pages 1501-1511.
Read now
Qiang Liu & Hong-Gang Wang. (2012) Anti-cancer drug discovery and development. Communicative & Integrative Biology 5:6, pages 557-565.
Read now

Articles from other publishers (145)

Sundra Dhakshinamurthy Saraswathy, Arumugam Mirunalini, Kandasamy Karthikeyan & Kumpati Premkumar. (2023) BH3 Mimetic Peptides: An Effective Strategy to Complement Anticancer Therapy. Current Protein & Peptide Science 24:10, pages 853-864.
Crossref
Wanqing Wang, Kaipeng Jiang, Xue Liu, Ju Li, Wenshuo Zhou, Chang Wang, Jiuwei Cui & Tingting Liang. (2023) FBXW7 and human tumors: mechanisms of drug resistance and potential therapeutic strategies. Frontiers in Pharmacology 14.
Crossref
Indy BuiStavroula BaritakiMassimo LibraApostolos ZaravinosBenjamin Bonavida. (2023) Cancer Resistance Is Mediated by the Upregulation of Several Anti-Apoptotic Gene Products via the Inducible Nitric Oxide Synthase/Nitric Oxide Pathway: Therapeutic Implications . Antioxidants & Redox Signaling 39:13-15, pages 853-889.
Crossref
Sandra Kannampuzha & Abilash Valsala Gopalakrishnan. (2023) Cancer chemoresistance and its mechanisms: Associated molecular factors and its regulatory role. Medical Oncology 40:9.
Crossref
Leticia Tamborlin, Karina Danielle Pereira, Dimitrius Santiago Passos Simões Fr Guimarães, Leonardo Reis Silveira & Augusto Ducati Luchessi. (2023) The first evidence of biological activity for free Hypusine, an enigmatic amino acid discovered in the '70s. Amino Acids 55:7, pages 913-929.
Crossref
Manzar Alam, Gulam Mustafa Hasan, Sayed M. Eldin, Mohd Adnan, Muhammad Bilal Riaz, Asimul Islam, Ilyas Khan & Md. Imtaiyaz Hassan. (2023) Investigating regulated signaling pathways in therapeutic targeting of non-small cell lung carcinoma. Biomedicine & Pharmacotherapy 161, pages 114452.
Crossref
Uly Sumarni, Jiaqi Zhu, Tobias Sinnberg & Jürgen Eberle. (2022) Sensitivity of Cutaneous T-Cell Lymphoma Cells to the Mcl-1 Inhibitor S63845 Correlates with the Lack of Bcl-w Expression. International Journal of Molecular Sciences 23:20, pages 12471.
Crossref
Kinga Krawiec, Piotr Strzałka, Magdalena Czemerska, Aneta Wiśnik, Izabela Zawlik, Agnieszka Wierzbowska & Agnieszka Pluta. (2022) Targeting Apoptosis in AML: Where Do We Stand?. Cancers 14:20, pages 4995.
Crossref
Danilo Ranieri, Deborah French, Flavia Persechino, Luisa Guttieri, Maria Rosaria Torrisi & Francesca Belleudi. (2022) The FGFR2c/PKCε Axis Controls MCL-1-Mediated Invasion in Pancreatic Ductal Adenocarcinoma Cells: Perspectives for Innovative Target Therapies. Biomedicines 10:7, pages 1652.
Crossref
Wenyue Shen, Quanwei Zhou, Chenxi Peng, Jiaheng Li, Qizhi Yuan, Hecheng Zhu, Ming Zhao, Xingjun Jiang, Weidong Liu & Caiping Ren. (2022) FBXW7 and the Hallmarks of Cancer: Underlying Mechanisms and Prospective Strategies. Frontiers in Oncology 12.
Crossref
Hilal Kalkan. 2022. Regulation and Dysfunction of Apoptosis. Regulation and Dysfunction of Apoptosis.
Elham Ebrahimi, Rima Manafi Shabestari, Davood Bashash & Majid Safa. (2022) Synergistic apoptotic effect of Mcl-1 inhibition and doxorubicin on B-cell precursor acute lymphoblastic leukemia cells. Molecular Biology Reports 49:3, pages 2025-2036.
Crossref
Kyung-Ho Park, Sang Hoon Joo, Ji-Hye Seo, Jumi Kim, Goo Yoon, Young-Joo Jeon, Mee-Hyun Lee, Jung-Il Chae, Woo-Keun Kim & Jung-Hyun Shim. (2022) Licochalcone H Induces Cell Cycle Arrest and Apoptosis in Human Skin Cancer Cells by Modulating JAK2/STAT3 Signaling. Biomolecules & Therapeutics 30:1, pages 72-79.
Crossref
Manzar Alam, Sabeeha Ali, Taj Mohammad, Gulam Mustafa Hasan, Dharmendra Kumar Yadav & Md. Imtaiyaz Hassan. (2021) B Cell Lymphoma 2: A Potential Therapeutic Target for Cancer Therapy. International Journal of Molecular Sciences 22:19, pages 10442.
Crossref
Manzar Alam & Rajakishore Mishra. (2021) Bcl-xL expression and regulation in the progression, recurrence, and cisplatin resistance of oral cancer. Life Sciences 280, pages 119705.
Crossref
Peng-Ju Zhu, Ze-Zhou Yu, Yi-Fei Lv, Jing-Long Zhao, Yuan-Yuan Tong, Qi-Dong You & Zheng-Yu Jiang. (2021) Discovery of 3,5-Dimethyl-4-Sulfonyl-1 H -Pyrrole-Based Myeloid Cell Leukemia 1 Inhibitors with High Affinity, Selectivity, and Oral Bioavailability . Journal of Medicinal Chemistry 64:15, pages 11330-11353.
Crossref
Fan Luo, Fei-Teng Lu, Miao-Zhen Qiu, Ting Zhou, Wen-Juan Ma, Min Luo, Kang-Mei Zeng, Qiu-Yun Luo, Wen-Tao Pan, Lin Zhang, Zeng-Fei Xia, Zhong-Han Zhang, Jia-Xin Cao, Hong-Yun Zhao, Li Zhang & Da-Jun Yang. (2021) Gemcitabine and APG-1252, a novel small molecule inhibitor of BCL-2/BCL-XL, display a synergistic antitumor effect in nasopharyngeal carcinoma through the JAK-2/STAT3/MCL-1 signaling pathway. Cell Death & Disease 12:8.
Crossref
Neha Mehrotra, Surender Kharbanda & Harpal Singh. (2021) BH3 mimetics in cancer therapy and their future perspectives with nanodelivery. Nanomedicine 16:13, pages 1067-1070.
Crossref
Masa Lasica & Mary Ann Anderson. (2021) Review of Venetoclax in CLL, AML and Multiple Myeloma. Journal of Personalized Medicine 11:6, pages 463.
Crossref
Haolan Wang, Ming Guo, Hudie Wei & Yongheng Chen. (2021) Targeting MCL-1 in cancer: current status and perspectives. Journal of Hematology & Oncology 14:1.
Crossref
Supusson Pengnam, Samarwadee Plianwong, Prasopchai Patrojanasophon, Widchaya Radchatawedchakoon, Boon-ek Yingyongnarongkul, Praneet Opanasopit & Purin Charoensuksai. (2021) Synergistic Effect of Doxorubicin and siRNA-Mediated Silencing of Mcl-1 Using Cationic Niosomes against 3D MCF-7 Spheroids. Pharmaceutics 13:4, pages 550.
Crossref
Lulu Li, Alagamuthu Karthick Kumar, Zhigang Hu & Zhigang Guo. (2021) Small Molecule Inhibitors Targeting Key Proteins in the DNA Damage Response for Cancer Therapy. Current Medicinal Chemistry 28:5, pages 963-985.
Crossref
Elżbieta Pędziwiatr-Werbicka, Michał Gorzkiewicz, Sylwia Michlewska, Maksim Ionov, Dzmitry Shcharbin, Barbara Klajnert-Maculewicz, Cornelia E. Peña-González, Javier Sánchez-Nieves, Rafael Gómez, F. Javier de la Mata & Maria Bryszewska. (2021) Evaluation of dendronized gold nanoparticles as siRNAs carriers into cancer cells. Journal of Molecular Liquids 324, pages 114726.
Crossref
Chong Li, Shiyu Feng & Ling Chen. (2020) MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway. Molecular and Cellular Biochemistry 476:2, pages 699-713.
Crossref
Dawei Wang, Ceji Fan & Jun Tang. (2021) Regorafenib Suppresses Migration of and Induces Cell Cycle Arrest and Apoptosis in MCF-7 Cells. Brazilian Journal of Pharmaceutical Sciences 57.
Crossref
Vivian Kosmidou, Margarita Vlassi, Kyriakos Anagiotos, Sofia Raftopoulou, Eirini Kalogerakou, Salomi Skarmalioraki, Chrysanthi Aggeli, Theodosia Choreftaki, George Zografos & Alexander Pintzas. (2020) Noxa upregulation and 5‐gene apoptotic biomarker panel in colorectal cancer . European Journal of Clinical Investigation 51:1.
Crossref
Karson J. Kump & Zaneta Nikolovska-Coleska. 2020. Protein – Protein Interaction Regulators. Protein – Protein Interaction Regulators 171 208 .
In-Hyoung Yang, Seung-Hyun Hong, Minjung Jung, Chi-Hyun Ahn, Hye-Jung Yoon, Seong Doo Hong, Sung-Dae Cho & Ji-Ae Shin. (2020) Cryptotanshinone chemosensitivity potentiation by TW-37 in human oral cancer cell lines by targeting STAT3–Mcl-1 signaling. Cancer Cell International 20:1.
Crossref
Andrew H. Wei, Andrew W. Roberts, Andrew Spencer, Aaron Seth Rosenberg, David Siegel, Roland B. Walter, Sean Caenepeel, Paul Hughes, Zach McIver, Khalid Mezzi, Phuong Khanh Morrow & Anthony Stein. (2020) Targeting MCL-1 in hematologic malignancies: Rationale and progress. Blood Reviews 44, pages 100672.
Crossref
Chongyang Li, Chaowei Deng, Guangzhao Pan, Xue Wang, Kui Zhang, Zhen Dong, Gaichao Zhao, Mengqin Tan, Xiaosong Hu, Shaomin Shi, Juan Du, Haoyan Ji, Xiaowen Wang, Liqun Yang & Hongjuan Cui. (2020) Lycorine hydrochloride inhibits cell proliferation and induces apoptosis through promoting FBXW7-MCL1 axis in gastric cancer. Journal of Experimental & Clinical Cancer Research 39:1.
Crossref
Nir Shahar & Sarit Larisch. (2020) Inhibiting the inhibitors: Targeting anti-apoptotic proteins in cancer and therapy resistance. Drug Resistance Updates 52, pages 100712.
Crossref
Parthiban Marimuthu, Jamoliddin Razzokov, Kalaimathy Singaravelu & Annemie Bogaerts. (2020) Predicted Hotspot Residues Involved in Allosteric Signal Transmission in Pro-Apoptotic Peptide—Mcl1 Complexes. Biomolecules 10:8, pages 1114.
Crossref
Michalina Respondek, Artur Beberok, Zuzanna Rzepka, Jakub Rok & Dorota Wrześniok. (2019) Mcl-1 Inhibitor Induces Cells Death in BRAF-Mutant Amelanotic Melanoma Trough GSH Depletion, DNA Damage and Cell Cycle Changes. Pathology & Oncology Research 26:3, pages 1465-1474.
Crossref
Qicheng Zhang, Mengmeng Chen, Limin Cao, Yinghui Ren, Xueru Guo, Xiang Wu & Ke Xu. (2020) Phenethyl isothiocyanate synergistically induces apoptosis with Gefitinib in non–small cell lung cancer cells via endoplasmic reticulum stress‐mediated degradation of Mcl‐1. Molecular Carcinogenesis 59:6, pages 590-603.
Crossref
Korrakod Petsri, Masashi Yokoya, Sucharat Tungsukruthai, Thanyada Rungrotmongkol, Bodee Nutho, Chanida Vinayanuwattikun, Naoki Saito, Takehiro Matsubara, Ryo Sato & Pithi Chanvorachote. (2020) Structure–Activity Relationships and Molecular Docking Analysis of Mcl-1 Targeting Renieramycin T Analogues in Patient-derived Lung Cancer Cells. Cancers 12:4, pages 875.
Crossref
Karson J. Kump, Lei Miao, Ahmed S. A. Mady, Nurul H. Ansari, Uttar K. Shrestha, Yuting Yang, Mohan Pal, Chenzhong Liao, Andrej Perdih, Fardokht A. Abulwerdi, Krishnapriya Chinnaswamy, Jennifer L. Meagher, Jacob M. Carlson, May Khanna, Jeanne A. Stuckey & Zaneta Nikolovska-Coleska. (2020) Discovery and Characterization of 2,5-Substituted Benzoic Acid Dual Inhibitors of the Anti-apoptotic Mcl-1 and Bfl-1 Proteins. Journal of Medicinal Chemistry 63:5, pages 2489-2510.
Crossref
Samarwadee Plianwong, Bindu Thapa, Remant Bahadur KC, Cezary Kucharski, Theerasak Rojanarata & Hasan Uludağ. (2020) Enabling Combinatorial siRNA Delivery against Apoptosis-Related Proteins with Linoleic Acid and α-Linoleic Acid Substituted Low Molecular Weight Polyethylenimines. Pharmaceutical Research 37:3.
Crossref
Wanatchaporn Arunmanee, Gea Abigail U. Ecoy, Hnin Ei Ei Khine, Methawee Duangkaew, Eakachai Prompetchara, Pithi Chanvorachote & Chatchai Chaotham. (2020) Colicin N Mediates Apoptosis and Suppresses Integrin-Modulated Survival in Human Lung Cancer Cells. Molecules 25:4, pages 816.
Crossref
Michalina Respondek, Artur Beberok, Zuzanna Rzepka, Jakub Rok & Dorota Wrześniok. (2019) MIM1 induces COLO829 melanoma cell death through mitochondrial membrane breakdown, GSH depletion, and DNA damage. Fundamental & Clinical Pharmacology 34:1, pages 20-31.
Crossref
Lesley Castillo, Adelaide I. J. Young, Amanda Mawson, Pia Schafranek, Angela M. Steinmann, Danielle Nessem, Ashleigh Parkin, Amber Johns, Angela Chou, Andrew M. K. Law, Morghan C. Lucas, Kendelle J. Murphy, Niantao Deng, David Gallego-Ortega, Catherine E. Caldon, Paul Timpson, Marina Pajic, Christopher J. Ormandy & Samantha R. Oakes. (2019) MCL-1 antagonism enhances the anti-invasive effects of dasatinib in pancreatic adenocarcinoma. Oncogene 39:8, pages 1821-1829.
Crossref
Gwenaella Rescourio, Ana Z. Gonzalez, Salman Jabri, Brian Belmontes, Gordon Moody, Doug Whittington, Xin Huang, Sean Caenepeel, Mario Cardozo, Alan C. Cheng, David Chow, Hannah Dou, Adrie Jones, Ron C. Kelly, Yihong Li, Mike Lizarzaburu, Mei-Chu Lo, Rommel Mallari, Cesar Meleza, Yosup Rew, Scott Simonovich, Daqing Sun, Simon Turcotte, Xuelei Yan, Simon G. Wong, Evelyn Yanez, Manuel Zancanella, Jonathan Houze, Julio C. Medina, Paul E. Hughes & Sean P. Brown. (2019) Discovery and in Vivo Evaluation of Macrocyclic Mcl-1 Inhibitors Featuring an α-Hydroxy Phenylacetic Acid Pharmacophore or Bioisostere. Journal of Medicinal Chemistry 62:22, pages 10258-10271.
Crossref
Yogesh Kumar Dhuriya, Divakar Sharma & Aijaz A. Naik. (2019) Cellular demolition: Proteins as molecular players of programmed cell death. International Journal of Biological Macromolecules 138, pages 492-503.
Crossref
Yonghai Zhang, Junzhao Li, Xianfeng Zhang, Guangzhong Gao, Jun Lu, Qin Zhang & Yasuo Ding. (2019) Inhibition of U87 Glioma Cell Growth by Baicalein Through Apoptosis Induction and Cell Cycle Arrest. International Journal of Pharmacology 15:7, pages 844-850.
Crossref
Chengzhi Wang, Manyi Yang, Jinfeng Zhao, Xia Li, Xiangcheng Xiao, Yang Zhang, Xin Jin & Mingmei Liao. (2018) Bile salt (glycochenodeoxycholate acid) induces cell survival and chemoresistance in hepatocellular carcinoma. Journal of Cellular Physiology 234:7, pages 10899-10906.
Crossref
Korrakod Petsri, Supakarn Chamni, Khanit Suwanborirux, Naoki Saito & Pithi Chanvorachote. (2019) Renieramycin T Induces Lung Cancer Cell Apoptosis by Targeting Mcl-1 Degradation: A New Insight in the Mechanism of Action. Marine Drugs 17:5, pages 301.
Crossref
Eleonora Turrini, Elena Catanzaro, Lorenzo Ferruzzi, Alessandra Guerrini, Massimo Tacchini, Gianni Sacchetti, Guglielmo Paganetto, Francesca Maffei, Valentina Pellicioni, Ferruccio Poli, Patrizia Hrelia, Manuela Mandrone, Piero Sestili, Maurizio Brigotti & Carmela Fimognari. (2019) Hemidesmus indicus induces apoptosis via proteasome inhibition and generation of reactive oxygen species. Scientific Reports 9:1.
Crossref
Xiangfeng Jin, Yi Yu, Qiang Zou, Mingzhao Wang, Yaojie Cui, Jing Xie & Zizong Wang. (2018) Retracted : MicroRNA‐105 promotes epithelial‐mesenchymal transition of nonsmall lung cancer cells through upregulating Mcl‐1 . Journal of Cellular Biochemistry 120:4, pages 5880-5888.
Crossref
Santanu Maji, Omprakash Shriwas, Sabindra K Samal, Manashi Priyadarshini, Rachna Rath, Sanjay Panda, Saroj Kumar Das Majumdar, Dillip Kumar Muduly & Rupesh Dash. (2019) STAT3- and GSK3β-mediated Mcl-1 regulation modulates TPF resistance in oral squamous cell carcinoma. Carcinogenesis 40:1, pages 173-183.
Crossref
Clare M. Adams, Sean Clark-Garvey, Pierluigi Porcu & Christine M. Eischen. (2019) Targeting the Bcl-2 Family in B Cell Lymphoma. Frontiers in Oncology 8.
Crossref
Antonietta Rosella Farina, Lucia Cappabianca, Pierdomenico Ruggeri, Luciana Gneo, Cristina Pellegrini, Maria-Concetta Fargnoli & Andrew Reay Mackay. (2018) The oncogenic neurotrophin receptor tropomyosin-related kinase variant, TrkAIII. Journal of Experimental & Clinical Cancer Research 37:1.
Crossref
Liang Guo, Sandy Eldridge, Michael Furniss, Jodie Mussio & Myrtle Davis. (2018) Role of Mcl-1 in regulation of cell death in human induced pluripotent stem cell-derived cardiomyocytes in vitro. Toxicology and Applied Pharmacology 360, pages 88-98.
Crossref
Jin‐Guo Yu, Cheng‐Hong Ji & Min‐Hua Shi. (2018) MicroRNA‐26b suppresses tumorigenicity and promotes apoptosis in small cell lung cancer cells by targeting myeloid cell leukemia 1 protein. The Kaohsiung Journal of Medical Sciences 34:11, pages 593-605.
Crossref
Anna De Blasio, Renza Vento & Riccardo Di Fiore. (2018) Mcl‐1 targeting could be an intriguing perspective to cure cancer. Journal of Cellular Physiology 233:11, pages 8482-8498.
Crossref
Eimear O’ Reilly, Sukhraj Pal S. Dhami, Denis V. Baev, Csaba Ortutay, Anna Halpin-McCormick, Ruth Morrell, Corrado Santocanale, Afshin Samali, John Quinn, Michael E O’Dwyer & Eva Szegezdi. (2018) Repression of Mcl-1 expression by the CDC7/CDK9 inhibitor PHA-767491 overcomes bone marrow stroma-mediated drug resistance in AML. Scientific Reports 8:1.
Crossref
Anjan K. Pradhan, Praveen Bhoopathi, Sarmistha Talukdar, Xue-Ning Shen, Luni Emdad, Swadesh K. Das, Devanand Sarkar & Paul B. Fisher. (2018) Recombinant MDA-7/IL24 Suppresses Prostate Cancer Bone Metastasis through Downregulation of the Akt/Mcl-1 Pathway. Molecular Cancer Therapeutics 17:9, pages 1951-1960.
Crossref
Ahmed S. A. Mady, Chenzhong Liao, Naval Bajwa, Karson J. Kump, Fardokht A. Abulwerdi, Katherine L. Lev, Lei Miao, Sierrah M. Grigsby, Andrej Perdih, Jeanne A. Stuckey, Yuhong Du, Haian Fu & Zaneta Nikolovska-Coleska. (2018) Discovery of Mcl-1 inhibitors from integrated high throughput and virtual screening. Scientific Reports 8:1.
Crossref
Srinivasulu Cheemanapalli, Anuradha C.M.Suresh Babu Pakala & Suresh Kumar Chitta. (2018) Design and screening of syringic acid analogues as BAX activators-An in silico approach to discover “BH3 mimetics”. Computational Biology and Chemistry 74, pages 49-62.
Crossref
Lin Zheng, Yum‑Shing Wong, Mumin Shao, Shiying Huang, Fochang Wang & Jianping Chen. (2018) Apoptosis induced by 9,11‑dehydroergosterol peroxide from Ganoderma�Lucidum mycelium in human malignant melanoma cells is Mcl‑1 dependent. Molecular Medicine Reports.
Crossref
Seong-Hoon Yun, Eun-Hye Sim, Sang-Heum Han, Jin-Yeong Han, Sung-Hyun Kim, Alexandra Silchenko, Valentin Stonik & Joo-In Park. (2018) Holotoxin A1 Induces Apoptosis by Activating Acid Sphingomyelinase and Neutral Sphingomyelinase in K562 and Human Primary Leukemia Cells. Marine Drugs 16:4, pages 123.
Crossref
Bonnie Williams, Anak Dharmapatni & Tania Crotti. (2017) Intracellular apoptotic pathways: a potential target for reducing joint damage in rheumatoid arthritis. Inflammation Research 67:3, pages 219-231.
Crossref
Yichao Wan, Ningning Dai, Zilong Tang & Hao Fang. (2018) Small-molecule Mcl-1 inhibitors: Emerging anti-tumor agents. European Journal of Medicinal Chemistry 146, pages 471-482.
Crossref
Seong-Hoon Yun, Eun-Hye Sim, Sang-Heum Han, Tae-Rang Kim, Mi-Ha Ju, Jin-Yeong Han, Jin-Sook Jeong, Sung-Hyun Kim, Alexandra S. Silchenko, Valentin A. Stonik & Joo-In Park. (2017) In vitro and in vivo anti-leukemic effects of cladoloside C2 are mediated by activation of Fas/ceramide synthase 6/p38 kinase/c-Jun NH2-terminal kinase/caspase-8 . Oncotarget 9:1, pages 495-511.
Crossref
Santanu Maji, Sanjay Panda, Sabindra K. Samal, Omprakash Shriwas, Rachna Rath, Maurizio Pellecchia, Luni Emdad, Swadesh K. Das, Paul B. Fisher & Rupesh Dash. 2018. 37 75 .
Ting Wang, Zhiwei Yang, Yimeng Zhang, Xiang Zhang, Lei Wang, Shengli Zhang & Lintao Jia. (2017) Caspase cleavage of Mcl-1 impairs its anti-apoptotic activity and proteasomal degradation in non-small lung cancer cells. Apoptosis 23:1, pages 54-64.
Crossref
Mohammad AshrafuzzamanMohammad Ashrafuzzaman. 2018. Nanoscale Biophysics of the Cell. Nanoscale Biophysics of the Cell 293 354 .
Claudia Morganti, Massimo Bonora, Luigi Sbano, Giampaolo Morciano, Giorgio Aquila, Gianluca Campo, Mariusz R. Wieckowski, Carlotta Giorgi & Paolo Pinton. 2018. Mitochondrial Biology and Experimental Therapeutics. Mitochondrial Biology and Experimental Therapeutics 47 73 .
Xinfang Yu, Wei Li, Zhenkun Xia, Li Xie, Xiaolong Ma, Qi Liang, Lijun Liu, Jian Wang, Xinmin Zhou, Yifeng Yang & Haidan Liu. (2017) Targeting MCL-1 sensitizes human esophageal squamous cell carcinoma cells to cisplatin-induced apoptosis. BMC Cancer 17:1.
Crossref
Tae-Ho Kang, Goo Yoon, In-A Kang, Ha-Na Oh, Jung-Il Chae & Jung-Hyun Shim. (2017) Natural Compound Licochalcone B Induced Extrinsic and Intrinsic Apoptosis in Human Skin Melanoma (A375) and Squamous Cell Carcinoma (A431) Cells. Phytotherapy Research 31:12, pages 1858-1867.
Crossref
Yang Xu, Zhixin Liang, Chunsun Li, Zhen Yang & Liangan Chen. (2017) LCMR1 interacts with DEK to suppress apoptosis in lung cancer cells. Molecular Medicine Reports 16:4, pages 4159-4164.
Crossref
Hanna Kędzierska & Agnieszka Piekiełko-Witkowska. (2017) Splicing factors of SR and hnRNP families as regulators of apoptosis in cancer. Cancer Letters 396, pages 53-65.
Crossref
Mao-Chuan Zhen, Fu-Qiang Wang, Shao-Feng Wu, Yi-Lin Zhao, Ping-Guo Liu & Zhen-Yu Yin. (2016) Identification of mTOR as a primary resistance factor of the IAP antagonist AT406 in hepatocellular carcinoma cells. Oncotarget 8:6, pages 9466-9475.
Crossref
Stanley R. Frankel & Dow-Chung Chi. 2017. Cancer Therapeutic Targets. Cancer Therapeutic Targets 833 850 .
Adelaide I. J. Young, Andrew M. K. Law, Lesley Castillo, Sabrina Chong, Hayley D. Cullen, Martin Koehler, Sebastian Herzog, Tilman Brummer, Erinna F. Lee, Walter D. Fairlie, Morghan C. Lucas, David Herrmann, Amr Allam, Paul Timpson, D. Neil Watkins, Ewan K. A. Millar, Sandra A. O’Toole, David Gallego-Ortega, Christopher J. Ormandy & Samantha R. Oakes. (2016) MCL-1 inhibition provides a new way to suppress breast cancer metastasis and increase sensitivity to dasatinib. Breast Cancer Research 18:1.
Crossref
Mohamed Elgendy, Amal Kamal Abdel-Aziz, Salvatore Lorenzo Renne, Viviana Bornaghi, Giuseppe Procopio, Maurizio Colecchia, Ravindran Kanesvaran, Chee Keong Toh, Daniela Bossi, Isabella Pallavicini, Jose Luis Perez-Gracia, Maria Dolores Lozano, Valeria Giandomenico, Ciro Mercurio, Luisa Lanfrancone, Nicola Fazio, Franco Nole, Bin Tean Teh, Giuseppe Renne & Saverio Minucci. (2016) Dual modulation of MCL-1 and mTOR determines the response to sunitinib. Journal of Clinical Investigation 127:1, pages 153-168.
Crossref
Kazutaka Ouchi, Yasumichi Kuwahara, Tomoko Iehara, Mitsuru Miyachi, Yoshiki Katsumi, Kunihiko Tsuchiya, Eiichi Konishi, Akio Yanagisawa & Hajime Hosoi. (2016) A NOXA/MCL-1 Imbalance Underlies Chemoresistance of Malignant Rhabdoid Tumor Cells. Journal of Cellular Physiology 231:9, pages 1932-1940.
Crossref
Xi-Yan Xiang, Jin-Song Kang, Xiao-Chun Yang, Jing Su, Yao Wu, Xiao-Yu Yan, Ya-Nan Xue, Ye Xu, Yu-He Liu, Chun-Yan Yu, Zhi-Chao Zhang & Lian-Kun Sun. (2016) SIRT3 participates in glucose metabolism interruption and apoptosis induced by BH3 mimetic S1 in ovarian cancer cells. International Journal of Oncology 49:2, pages 773-784.
Crossref
FANG WANG, JINCHENG XU, HAO LIU, ZHE LIU & FEI XIA. (2016) Metformin induces apoptosis by microRNA-26a-mediated downregulation of myeloid cell leukaemia-1 in human oral cancer cells. Molecular Medicine Reports 13:6, pages 4671-4676.
Crossref
Xiufen Liu, Fabian Müller, Alan S. Wayne & Ira Pastan. (2016) Protein Kinase Inhibitor H89 Enhances the Activity of Pseudomonas Exotoxin A–Based Immunotoxins . Molecular Cancer Therapeutics 15:5, pages 1053-1062.
Crossref
Masayuki Hiraki, Yozo Suzuki, Maroof Alam, Kunihiko Hinohara, Masanori Hasegawa, Caining Jin, Surender Kharbanda & Donald Kufe. (2016) MUC1-C Stabilizes MCL-1 in the Oxidative Stress Response of Triple-Negative Breast Cancer Cells to BCL-2 Inhibitors. Scientific Reports 6:1.
Crossref
Andrew M. Beekman & Lesley A. Howell. (2016) Small-Molecule and Peptide Inhibitors of the Pro-Survival Protein Mcl-1. ChemMedChem 11:8, pages 802-813.
Crossref
Haiming Dai, X. Wei Meng & Scott H. Kaufmann. (2016) Mitochondrial apoptosis and BH3 mimetics. F1000Research 5, pages 2804.
Crossref
Haifei He, Wei Tian, Hailong Chen & Yongchuan Deng. (2015) MicroRNA-101 sensitizes hepatocellular carcinoma cells to doxorubicin-induced apoptosis via targeting Mcl-1. Molecular Medicine Reports.
Crossref
Neel M. Fofaria, Dennie T. Frederick, Ryan J. Sullivan, Keith T. Flaherty & Sanjay K. Srivastava. (2015) Overexpression of Mcl-1 confers resistance to BRAFV600E inhibitors alone and in combination with MEK1/2 inhibitors in melanoma. Oncotarget 6:38, pages 40535-40556.
Crossref
Ramzi M. Mohammad, Irfana Muqbil, Leroy Lowe, Clement Yedjou, Hsue-Yin Hsu, Liang-Tzung Lin, Markus David Siegelin, Carmela Fimognari, Nagi B. Kumar, Q. Ping Dou, Huanjie Yang, Abbas K. Samadi, Gian Luigi Russo, Carmela Spagnuolo, Swapan K. Ray, Mrinmay Chakrabarti, James D. Morre, Helen M. Coley, Kanya Honoki, Hiromasa Fujii, Alexandros G. Georgakilas, Amedeo Amedei, Elena Niccolai, Amr Amin, S. Salman Ashraf, William G. Helferich, Xujuan Yang, Chandra S. Boosani, Gunjan Guha, Dipita Bhakta, Maria Rosa Ciriolo, Katia Aquilano, Sophie Chen, Sulma I. Mohammed, W. Nicol Keith, Alan Bilsland, Dorota Halicka, Somaira Nowsheen & Asfar S. Azmi. (2015) Broad targeting of resistance to apoptosis in cancer. Seminars in Cancer Biology 35, pages S78-S103.
Crossref
JUNG JAE CHO, JUNG-IL CHAE, KA HWI KIM, JIN HYOUNG CHO, YOUNG-JOO JEON, HA NA OH, GOO YOON, DO YOUNG YOON, YOUNG SIK CHO, SEUNG-SIK CHO & JUNG-HYUN SHIM. (2015) Manumycin A from a new Streptomyces strain induces endoplasmic reticulum stress-mediated cell death through specificity protein 1 signaling in human oral squamous cell carcinoma. International Journal of Oncology 47:5, pages 1954-1962.
Crossref
Ren? Weiss, Johannes Laengle, Monika Sachet, Anna-Polina Shurygina, Oleg Kiselev, Andrej Egorov & Michael Bergmann. (2015) Interleukin-24 inhibits influenza A virus replication in vitro through induction of toll-like receptor 3 dependent apoptosis. Antiviral Research 123, pages 93-104.
Crossref
Surong Zhao, Hongmei Li, Chenchen Jiang, Tao Ma, Chengzhu Wu, Qiang Huo & Hao Liu. (2015) 17-Demethoxy-reblastatin, an Hsp90 inhibitor, induces mitochondria-mediated apoptosis through downregulation of Mcl-1 in human hepatocellular carcinoma cells. Journal of Bioenergetics and Biomembranes 47:5, pages 373-381.
Crossref
Qiongrong Chen, Shumei Song, Shaozhong Wei, Bin Liu, Soichiro Honjo, Ailing Scott, Jiankang Jin, Lang Ma, Haitao Zhu, Heath D. Skinner, Randy L. Johnson & Jaffer A. Ajani. (2015) ABT-263 induces apoptosis and synergizes with chemotherapy by targeting stemness pathways in esophageal cancer. Oncotarget 6:28, pages 25883-25896.
Crossref
Lavinia Liguori, Fabio Pastorino, Xavier Rousset, Silvia Alfano, Sandra Cortes, Laura Emionite, Antonio Daga, Mirco Ponzoni & Jean-Luc Lenormand. (2015) Anti-Tumor Effects of Bak-Proteoliposomes against Glioblastoma. Molecules 20:9, pages 15893-15909.
Crossref
Nabanita Mukherjee, Josianna V. Schwan, Mayumi Fujita, David A. Norris & Yiqun G. Shellman. (2015) Alternative Treatments For Melanoma: Targeting BCL-2 Family Members to De-Bulk and Kill Cancer Stem Cells. Journal of Investigative Dermatology 135:9, pages 2155-2161.
Crossref
Lorenza Pasqualini, Huajie Bu, Martin Puhr, Narisu Narisu, Johannes Rainer, Bettina Schlick, Georg Schäfer, Mihaela Angelova, Zlatko Trajanoski, Stefan T. Börno, Michal R. Schweiger, Christian Fuchsberger & Helmut Klocker. (2015) miR-22 and miR-29a Are Members of the Androgen Receptor Cistrome Modulating LAMC1 and Mcl-1 in Prostate Cancer. Molecular Endocrinology 29:7, pages 1037-1054.
Crossref
Cristina Correia, Sun-Hee Lee, X. Wei Meng, Nicole D. Vincelette, Katherine L.B. Knorr, Husheng Ding, Grzegorz S. Nowakowski, Haiming Dai & Scott H. Kaufmann. (2015) Emerging understanding of Bcl-2 biology: Implications for neoplastic progression and treatment. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1853:7, pages 1658-1671.
Crossref
Santanu Maji, Sabindra K Samal, Laxmipriya Pattanaik, Swagatika Panda, Bridget A. Quinn, Swadesh K. Das, Devanand Sarkar, Maurizio Pellecchia, Paul B. Fisher & Rupesh Dash. (2015) Mcl-1 is an important therapeutic target for oral squamous cell carcinomas. Oncotarget 6:18, pages 16623-16637.
Crossref
Stephen M. Madamba, Kevin N. Damri, Laurent M. Dejean & Pablo M. Peixoto. (2015) Mitochondrial Ion Channels in Cancer Transformation. Frontiers in Oncology 5.
Crossref
Bridget A. Quinn, Rupesh Dash, Siddik Sarkar, Belal Azab, Praveen Bhoopathi, Swadesh K. Das, Luni Emdad, Jun Wei, Maurizio Pellecchia, Devanand Sarkar & Paul B. Fisher. (2015) Pancreatic Cancer Combination Therapy Using a BH3 Mimetic and a Synthetic Tetracycline. Cancer Research 75:11, pages 2305-2315.
Crossref
Siddik Sarkar, Bridget A. Quinn, Xue-Ning Shen, Rupesh Dash, Swadesh K. Das, Luni Emdad, Alexander L. Klibanov, Xiang-Yang Wang, Maurizio Pellecchia, Devanand Sarkar & Paul B. Fisher. (2015) Therapy of prostate cancer using a novel cancer terminator virus and a small molecule BH-3 mimetic. Oncotarget 6:13, pages 10712-10727.
Crossref
WAN-SIK LEE, YOUNG-LAN PARK, NURI KIM, HYUNG-HOON OH, DONG-JUN SON, MI-YOUNG KIM, CHAN-YOUNG OAK, CHO-YUN CHUNG, HYUNG-CHUL PARK, JONG-SUN KIM, DAE-SEONG MYUNG, SUNG-BUM CHO & YOUNG-EUN JOO. (2015) Myeloid cell leukemia-1 regulates the cell growth and predicts prognosis in gastric cancer. International Journal of Oncology 46:5, pages 2154-1262.
Crossref
Michael T. Burke, Christudas Morais, Kimberley A. Oliver, Duncan L. J. Lambie, Glenda C. Gobe, Robert P. Carroll, Christine E. Staatz, Sudipta Sinnya, H. Peter Soyer, Clay WinterfordNikolas K. Haass, Scott B. Campbell & Nicole M. Isbel. (2015) Expression of Bcl-xL and Mcl-1 in the Nonmelanoma Skin Cancers of Renal Transplant Recipients. American Journal of Clinical Pathology 143:4, pages 514-526.
Crossref
Yang Zhang, Xiaobo Zhu, Kun Hou, Jinchuan Zhao, Zhiguo Han & Xiaona Zhang. (2015) Mcl-1 downregulation sensitizes glioma to bortezomib-induced apoptosis. Oncology Reports.
Crossref
Frédéric R. Santer, Holger H. H. Erb, Su Jung Oh, Florian Handle, Gertrud E. Feiersinger, Birgit Luef, Huajie Bu, Georg Schäfer, Christian Ploner, Martina Egger, Jayant K. Rane, Norman J. Maitland, Helmut Klocker, Iris E. Eder & Zoran Culig. (2015) Mechanistic rationale for MCL1 inhibition during androgen deprivation therapy. Oncotarget 6:8, pages 6105-6122.
Crossref
Michele Modugno, Patrizia Banfi, Fabio Gasparri, Robert Borzilleri, Percy Carter, Lyndon Cornelius, Marco Gottardis, Ving Lee, Claudio Mapelli, Joseph G. Naglich, Andrew Tebben, Gregory Vite, Wilma Pastori, Clara Albanese, Emiliana Corti, Dario Ballinari & Arturo Galvani. (2015) Mcl-1 antagonism is a potential therapeutic strategy in a subset of solid cancers. Experimental Cell Research 332:2, pages 267-277.
Crossref
Céline Gloaguen, Anne Sophie Voisin-Chiret, Jana Sopkova-de Oliveira Santos, Jade Fogha, Fabien Gautier, Marcella De Giorgi, Grégory Burzicki, Serge Perato, Cécile Pétigny-Lechartier, Karin Simonin-Le Jeune, Emilie Brotin, Didier Goux, Monique N’Diaye, Bernard Lambert, Marie-Hélène Louis, Laetitia Ligat, Frédéric Lopez, Philippe Juin, Ronan Bureau, Sylvain Rault & Laurent Poulain. (2015) First Evidence That Oligopyridines, α-Helix Foldamers, Inhibit Mcl-1 and Sensitize Ovarian Carcinoma Cells to Bcl-x L -Targeting Strategies . Journal of Medicinal Chemistry 58:4, pages 1644-1668.
Crossref
Bridget A. Quinn, Nathaniel A. Lee, Timothy P. Kegelman, Praveen Bhoopathi, Luni Emdad, Swadesh K. Das, Maurizio Pellecchia, Devanand Sarkar & Paul B. Fisher. 2015. 283 306 .
Klaus Podar. 2017. Encyclopedia of Cancer. Encyclopedia of Cancer 2682 2683 .
Klaus Podar. 2016. Encyclopedia of Cancer. Encyclopedia of Cancer 1 2 .
Mohamed Elgendy, Marco Ciro, Amal Kamal Abdel-Aziz, Giuseppe Belmonte, Roberto Dal Zuffo, Ciro Mercurio, Clelia Miracco, Luisa Lanfrancone, Marco Foiani & Saverio Minucci. (2014) Beclin 1 restrains tumorigenesis through Mcl-1 destabilization in an autophagy-independent reciprocal manner. Nature Communications 5:1.
Crossref
Mengchang Wang, Di Wu, Pengbo Liu & Jiusheng Deng. (2014) Silence of MCL-1 upstream signaling by shRNA abrogates multiple myeloma growth. Experimental Hematology & Oncology 3:1.
Crossref
Bin Wang, Zhenhong Ni, Xufang Dai, Liyan Qin, Xinzhe Li, Liang Xu, Jiqin Lian & Fengtian He. (2014) The Bcl-2/xL inhibitor ABT-263 increases the stability of Mcl-1 mRNA and protein in hepatocellular carcinoma cells. Molecular Cancer 13:1.
Crossref
Xiwei Ding, Bin Zhang, Qingshan Pei, Jianmei Pan, Shuling Huang, Yan Yang, Zhu Zhu, Ying Lv & Xiaoping Zou. (2014) Triptolide induces apoptotic cell death of human cholangiocarcinoma cells through inhibition of myeloid cell leukemia-1. BMC Cancer 14:1.
Crossref
Vinayak Palve, Sanchita Mallick, Gauri Ghaisas, Sadhana Kannan & Tanuja Teni. (2014) Overexpression of Mcl-1L Splice Variant Is Associated with Poor Prognosis and Chemoresistance in Oral Cancers. PLoS ONE 9:11, pages e111927.
Crossref
Massimo Bonora & Paolo Pinton. (2014) The Mitochondrial Permeability Transition Pore and Cancer: Molecular Mechanisms Involved in Cell Death. Frontiers in Oncology 4.
Crossref
Claudia Cerella, Marie-Hélène Teiten, Flavia Radogna, Mario Dicato & Marc Diederich. (2014) From nature to bedside: Pro-survival and cell death mechanisms as therapeutic targets in cancer treatment. Biotechnology Advances 32:6, pages 1111-1122.
Crossref
Eun-Ryeong Hahm, Joomin Lee & Shivendra V. Singh. (2014) Role of mitogen-activated protein kinases and Mcl-1 in apoptosis induction by withaferin A in human breast cancer cells. Molecular Carcinogenesis 53:11, pages 907-916.
Crossref
Tomi K. Sawyer, Vincent Guerlavais, Krzysztof Darlak & Eric Feyfant. 2014. Macrocycles in Drug Discovery. Macrocycles in Drug Discovery 339 366 .
Frankie Lam, Abdullahi Y. Abbas, Hao Shao, Theodosia Teo, Julian Adams, Peng Li, Tracey D. Bradshaw, Peter M. Fischer, Elisabeth Walsby, Chris Pepper, Yi Chen, Jian Ding & Shudong Wang. (2014) Targeting RNA transcription and translation in ovarian cancer cells with pharmacological inhibitor CDKI-73. Oncotarget 5:17, pages 7691-7704.
Crossref
Yang Gao, Sumita Trivedi, Robert L. Ferris & Kazunori Koide. (2014) Regulation of HPV16 E6 and MCL1 by SF3B1 inhibitor in head and neck cancer cells. Scientific Reports 4:1.
Crossref
Yosuke Konno, Peixin Dong, Ying Xiong, Fumihiko Suzuki, Jiabin Lu, Muyan Cai, Hidemichi Watari, Takashi Mitamura, Masayoshi Hosaka, Sharon J. B. Hanley, Masataka Kudo & Noriaki Sakuragi. (2014) MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells. Oncotarget 5:15, pages 6049-6062.
Crossref
Shanna K. Nifoussi, Nora R. Ratcliffe, Deborah L. Ornstein, Gary Kasof, Stefan Strack & Ruth W. Craig. (2014) Inhibition of Protein Phosphatase 2A (PP2A) Prevents Mcl-1 Protein Dephosphorylation at the Thr-163/Ser-159 Phosphodegron, Dramatically Reducing Expression in Mcl-1-amplified Lymphoma Cells. Journal of Biological Chemistry 289:32, pages 21950-21959.
Crossref
J Yan, N Zhong, G Liu, K Chen, X Liu, L Su & S Singhal. (2014) Usp9x- and Noxa-mediated Mcl-1 downregulation contributes to pemetrexed-induced apoptosis in human non-small-cell lung cancer cells. Cell Death & Disease 5:7, pages e1316-e1316.
Crossref
Jennifer L. Schacter, Elizabeth S. Henson & Spencer B. Gibson. (2014) Estrogen Regulation of Anti-Apoptotic Bcl-2 Family Member Mcl-1 Expression in Breast Cancer Cells. PLoS ONE 9:6, pages e100364.
Crossref
Jian-guo Sun, Hua Li, Xia Li, Xueli Zeng, Ping Wu, Kwok-Pui Fung & Fei-yan Liu. (2014) Clitocine targets Mcl-1 to induce drug-resistant human cancer cell apoptosis in vitro and tumor growth inhibition in vivo. Apoptosis 19:5, pages 871-882.
Crossref
Timothy G. Whitsett, Ian T. Mathews, Michael H. Cardone, Ryan J. Lena, William E. Pierceall, Michael Bittner, Chao Sima, Janine LoBello, Glen J. Weiss & Nhan L. Tran. (2014) Mcl-1 Mediates TWEAK/Fn14-Induced Non–Small Cell Lung Cancer Survival and Therapeutic Response. Molecular Cancer Research 12:4, pages 550-559.
Crossref
Á. C. Murphy, B. Weyhenmeyer, J. Noonan, S. M. Kilbride, S. Schimansky, K. P. Loh, D. Kögel, A. G. Letai, J. H. M. Prehn & B. M. Murphy. (2013) Modulation of Mcl-1 sensitizes glioblastoma to TRAIL-induced apoptosis. Apoptosis 19:4, pages 629-642.
Crossref
Fengjuan Fan, Giovanni Tonon, Muhammad Hasan Bashari, Sonia Vallet, Elena Antonini, Hartmut Goldschmidt, Henning Schulze-Bergkamen, Joseph T. Opferman, Martin Sattler, Kenneth C. Anderson, Dirk Jäger & Klaus Podar. (2014) Targeting Mcl-1 for multiple myeloma (MM) therapy: Drug-induced generation of Mcl-1 fragment Mcl-1128–350 triggers MM cell death via c-Jun upregulation. Cancer Letters 343:2, pages 286-294.
Crossref
Hadi Karami, Behzad Baradaran, Ali Esfehani, Masoud Sakhinia & Ebrahim Sakhinia. (2014) Down-Regulation of Mcl-1 by Small Interference RNA Induces Apoptosis and Sensitizes HL-60 Leukemia Cells to Etoposide. Asian Pacific Journal of Cancer Prevention 15:2, pages 629-635.
Crossref
Xiao Ding, Yan Li, Li Lv, Mi Zhou, Li Han, Zhengxi Zhang, Qian Ba, Jingquan Li, Hui Wang, Hong Liu & Renxiao Wang. (2013) De Novo Design, Synthesis and Evaluation of Benzylpiperazine Derivatives as Highly Selective Binders of Mcl-1. ChemMedChem 8:12, pages 1986-2014.
Crossref
Manoj K. Pandey, Krishne Gowda, Kenichiro Doi, Arun K. Sharma, Hong-Gang Wang & Shantu Amin. (2013) Proteasomal Degradation of Mcl-1 by Maritoclax Induces Apoptosis and Enhances the Efficacy of ABT-737 in Melanoma Cells. PLoS ONE 8:11, pages e78570.
Crossref
Giuseppe Giaccone & Jean-Charles SoriaPamela Holland, David Reese & Jeffrey Wiezorek. 2013. Targeted Therapies in Oncology, Second Edition. Targeted Therapies in Oncology, Second Edition 253 282 .
Li Zhou, Tianzhu Qiu, Jing Xu, Tongshan Wang, Jian Wang, Xin Zhou, Zebo Huang, Wei Zhu, Yongqian Shu & Ping Liu. (2013) miR-135a/b Modulate Cisplatin Resistance of Human Lung Cancer Cell Line by Targeting MCL1. Pathology & Oncology Research 19:4, pages 677-683.
Crossref
Hongwei Yao, Shuofu Mi, Weibin Gong, Jian Lin, Nuo Xu, Sarah Perrett, Bin Xia, Jinfeng Wang & Yingang Feng. (2013) Anti-apoptosis Proteins Mcl-1 and Bcl-xL Have Different p53-Binding Profiles. Biochemistry 52:37, pages 6324-6334.
Crossref
Christian Billard. (2013) BH3 Mimetics: Status of the Field and New Developments. Molecular Cancer Therapeutics 12:9, pages 1691-1700.
Crossref
Nian‐Kang Sun, Shang‐Lang Huang, Ting‐Chang Chang & Chuck C.‐K. Chao. (2013) Sorafenib induces endometrial carcinoma apoptosis by inhibiting Elk‐1‐dependent Mcl‐1 transcription and inducing Akt/GSK3β‐dependent protein degradation. Journal of Cellular Biochemistry 114:8, pages 1819-1831.
Crossref
Philippe Juin, Olivier Geneste, Fabien Gautier, Stéphane Depil & Mario Campone. (2013) Decoding and unlocking the BCL-2 dependency of cancer cells. Nature Reviews Cancer 13:7, pages 455-465.
Crossref
Chia‐Ming Chang & Chih Chang Chao. (2013) Protein kinase CK2 enhances Mcl‐1 gene expression through the serum response factor‐mediated pathway in the rat hippocampus . Journal of Neuroscience Research 91:6, pages 808-817.
Crossref
J Bertin-Ciftci, B Barré, J Le Pen, L Maillet, C Couriaud, P Juin & F Braun. (2013) pRb/E2F-1-mediated caspase-dependent induction of Noxa amplifies the apoptotic effects of the Bcl-2/Bcl-xL inhibitor ABT-737. Cell Death & Differentiation 20:5, pages 755-764.
Crossref
Mariana Boiani, Cristina Daniel, Xueyuan Liu, Michael D. Hogarty & Lawrence J. Marnett. (2013) The Stress Protein BAG3 Stabilizes Mcl-1 Protein and Promotes Survival of Cancer Cells and Resistance to Antagonist ABT-737. Journal of Biological Chemistry 288:10, pages 6980-6990.
Crossref
Sílvia Xargay-Torrent, Mónica López-Guerra, Arnau Montraveta, Ifigènia Saborit-Villarroya, Laia Rosich, Alba Navarro, Patricia Pérez-Galán, Gaël Roué, Elias Campo & Dolors Colomer. (2013) Sorafenib Inhibits Cell Migration and Stroma-Mediated Bortezomib Resistance by Interfering B-cell Receptor Signaling and Protein Translation in Mantle Cell Lymphoma. Clinical Cancer Research 19:3, pages 586-597.
Crossref
Maurizio Pellecchia. (2012) Antagonists of Protein–Protein Interactions Made Easy?. Journal of Medicinal Chemistry 56:1, pages 13-14.
Crossref
Denis Drygin. 2013. Protein Kinase CK2. Protein Kinase CK2 383 439 .
William Garland, Robert Benezra & Jaideep Chaudhary. 2013. 227 245 .
Stanley R Frankel & Dow-Chung Chi. 2016. Cancer Therapeutic Targets. Cancer Therapeutic Targets 1 18 .
Pierfausto Seneci. (2012) Small molecules as pro-apoptotic anticancer agents. Pharmaceutical Patent Analyst 1:4, pages 483-505.
Crossref
EUN-SUN CHOI, JUN-SUNG KIM, KI-HAN KWON, HYNG-SEOP KIM, NAM-PYO CHO & SUNG-DAE CHO. (2012) Methanol extract of Sanguisorba officinalis L. with cytotoxic activity against PC3 human prostate cancer cells. Molecular Medicine Reports 6:3, pages 670-674.
Crossref
Kenichiro Doi, Rongshi Li, Shen-Shu Sung, Hongwei Wu, Yan Liu, Wanda Manieri, Gowdahalli Krishnegowda, Andy Awwad, Alden Dewey, Xin Liu, Shantu Amin, Chunwei Cheng, Yong Qin, Ernst Schonbrunn, Gary Daughdrill, Thomas P. LoughranJr.Jr., Said Sebti & Hong-Gang Wang. (2012) Discovery of Marinopyrrole A (Maritoclax) as a Selective Mcl-1 Antagonist that Overcomes ABT-737 Resistance by Binding to and Targeting Mcl-1 for Proteasomal Degradation. Journal of Biological Chemistry 287:13, pages 10224-10235.
Crossref
Gregory J. Gores & Scott H. Kaufmann. (2012) Selectively targeting Mcl-1 for the treatment of acute myelogenous leukemia and solid tumors: Figure 1.. Genes & Development 26:4, pages 305-311.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.